BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
U.K.'s Competition and Markets Authority has fined GlaxoSmithKline P.L.C. £37.6 million ($54.4 million) over pay-for-delay deals that delayed sales of cheaper, generic versions of its anti-depressant Seroxat, reported Bloomberg.
GSK conspired with other firms from 2001 to 2004 to make payments totaling more than £50 million to suppliers of generic versions of paroxetine, the CMA said. The CMA has also fined firms including German drugmaker Merck KGaA, Dutch firm Mylan N.V. and Actavis U.K. Ltd. as part of the probe.
1. Turkish airlines cancel flights to Iran and Iraq amid war concerns
3. Zurich Insurance to stop underwriting new oil and gas projects
4. Bermudan, European reinsurers to suffer major hit from bridge collapse
5. Tycoon gets death sentence for multi-billion-dollar fraud
6. Inflation drives 10% increase in sum insured for windstorms